Physician

Belisario Augusto Arango, MD

According to 2025 Medicare claims, Belisario Arango, MD (NPI: 1295976827) practices hematology/oncology in the Ogden, UT market, with the plurality of this provider's patient population coming from Weber, UT. This provider's primary affiliated billing organization is UTAH CANCER SPECIALISTS PC (NPI: 1619925369; TIN: 870519691) and primary practice location at 84405-6901.

Arango's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 205 traditional Medicare patients, billed 87,162 HCPCS/CPT codes, and received $1,094,143 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,016 prescription claims across 166 beneficiaries totaling $1,899,526 in drug costs, led by Revlimid (Lenalidomide). 2020 DME data shows 37 claims. Open Payments data shows 46 records totaling $13,529. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $72,654 and ending at $1,094,143. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $759,519 and ending at $1,899,526. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $8,123 to $2,610.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2015 Medicare payment: $72,654 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $35,521 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $35,715 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $228,211 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,293,878 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,376,482 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $685,014 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,058,910 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $634,479 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,094,143 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153191,307$72,654
2016275701$35,521
2017291775$35,715
201827819,300$228,211
2019236110,237$1,293,878
2020310236,035$2,376,482
202120371,555$685,014
202212462,701$1,058,910
202317353,508$634,479
202420587,162$1,094,143

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$950K$1.9M2015 Drug cost: $759,519 (USD; Tot_Drug_Cst)2016 Drug cost: $842,092 (USD; Tot_Drug_Cst)2017 Drug cost: $810,983 (USD; Tot_Drug_Cst)2018 Drug cost: $459,475 (USD; Tot_Drug_Cst)2019 Drug cost: $607,292 (USD; Tot_Drug_Cst)2020 Drug cost: $632,458 (USD; Tot_Drug_Cst)2021 Drug cost: $477,644 (USD; Tot_Drug_Cst)2022 Drug cost: $952,770 (USD; Tot_Drug_Cst)2023 Drug cost: $726,043 (USD; Tot_Drug_Cst)2024 Drug cost: $1,899,526 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015130954$759,519
20161371,006$842,092
2017138845$810,983
2018102446$459,475
201961391$607,292
202071661$632,458
202177392$477,644
202294691$952,770
2023105649$726,043
20241661,016$1,899,526

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.0K$8.1K2015 Medicare payment: $8,080 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $7,051 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $3,584 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,064 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R98$8,080
2016N/R108$7,051
2017N/R55$3,584
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R37$2,064
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more112287$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more73107$62
82728Ferritin (blood protein) level5292$13
80053Blood test, comprehensive group of blood chemicals146448$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count161506$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide20560$363,123
XtandiEnzalutamide23684$319,783
CalquenceAcalabrutinib Maleate16480$197,795
LenalidomideLenalidomide13364$194,967
VerzenioAbemaciclib12336$182,085

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.46$13,529Daiichi Sankyo Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Belisario Augusto Arango, MD?

Tedicare shows public-source Medicare data for Belisario Augusto Arango, MD (NPI 1295976827), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Belisario Augusto Arango, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Belisario Augusto Arango, MD?

Belisario Augusto Arango, MD is linked to UTAH CANCER SPECIALISTS PC (billing NPI 1619925369) in the available physician profile data.

Does Belisario Augusto Arango, MD have Open Payments data?

Belisario Augusto Arango, MD has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.